NCTId,BriefTitle,OverallStatus,StudyType,Phases,Conditions,LeadSponsorName,StartDate,StudyFirstPostDate,LastUpdatePostDate,Timestamp
NCT02752048,A Phase IIa Study of TAS-205 for Duchenne Muscular Dystrophy,COMPLETED,INTERVENTIONAL,PHASE2,Duchenne Muscular Dystrophy,"Taiho Pharmaceutical Co., Ltd.",2016-05,2016-04-26,2020-04-20,2024-10-30T07:18:11.016239
NCT04626674,A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD),ACTIVE_NOT_RECRUITING,INTERVENTIONAL,PHASE1,"Muscular Dystrophy, Duchenne","Sarepta Therapeutics, Inc.",2020-11-23,2020-11-12,2024-08-26,2024-10-30T07:18:11.016239
NCT02285673,Efficacy of Umbilical Cord Mesenchymal Stem Cells in Duchenne Muscular Dystrophy,UNKNOWN,INTERVENTIONAL,"PHASE1, PHASE2",Duchenne Muscular Dystrophy,Acibadem University,2013-11,2014-11-07,2014-11-07,2024-10-30T07:18:11.016239
